Cambridge Investment Research Advisors
IMGN

Cambridge Investment Research Advisors’s Immunogen Inc IMGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,362
Closed -$339K – 3325
2023
Q3 		$339K Sell
21,362
-2,071
-9% -$34.4K ﹤0.01% 2411
2023
Q2 		$442K Sell
23,433
-27,968
-54% -$330K ﹤0.01% 2228
2023
Q1 		$197K Buy
51,401
+636
+1% +$2.71K ﹤0.01% 2836
2022
Q4 		$252K Sell
50,765
-2,698
-5% -$14.6K ﹤0.01% 2568
2022
Q3 		$256K Sell
53,463
-100
-0.2% -$527 ﹤0.01% 2498
2022
Q2 		$241K Buy
53,563
+25,589
+91% +$111K ﹤0.01% 2570
2022
Q1 		$133K Buy
27,974
+99
+0.4% +$548 ﹤0.01% 2969
2021
Q4 		$207K Buy
27,875
+9,188
+49% +$57.1K ﹤0.01% 2869
2021
Q3 		$106K Buy
+18,687
New +$108K ﹤0.01% 2947
2021
Q1 		– Sell
-17,373
Closed -$112K – 3012
2020
Q4 		$112K Sell
17,373
-2,493
-13% -$14.5K ﹤0.01% 2586
2020
Q3 		$72K Buy
19,866
+100
+0.5% +$404 ﹤0.01% 2425
2020
Q2 		$91K Hold
19,766
– – ﹤0.01% 2326
2020
Q1 		$67K Buy
+19,766
New +$86.4K ﹤0.01% 2161
2014
Q2 		– Sell
-18,358
Closed -$274K – 1379
2014
Q1 		$274K Buy
18,358
+2,950
+19% +$46.5K 0.01% 995
2013
Q4 		$226K Buy
15,408
+700
+5% +$10.8K 0.01% 1016
2013
Q3 		$250K Buy
14,708
+800
+6% +$14.1K 0.01% 938
2013
Q2 		$231K Buy
+13,908
New +$225K 0.01% 879

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cambridge Investment Research Advisors's IMGN Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 21,362 shares — an estimated $339K sold.

Cambridge Investment Research Advisors first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $442K in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 21,362 Immunogen Inc shares in Q4 2023, an estimated $339K.
  • Cambridge Investment Research Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
  • Cambridge Investment Research Advisors's Immunogen Inc position peaked at $442K in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.